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Summary and Conclusions 
Milk proteins can be hydrolysed (i.e. fragmented) using proteolytic enzymes to give 
enhanced functional and nutritional properties. There is an increasing demand for 
hydrolysed protein ingredients with specific properties for nutrition of individuals with 
specialised dietary requirements including infants, the critically ill, the immuno-compromised 
and athletes. Such hydrolysed proteins can be specifically designed to provide distinctive 
tailor-made solutions to meet customer needs in these areas. This project explored the 
technologies for the production of two types of hydrolysates i.e. acid-soluble and glutamine-
rich. Acid-soluble protein hydrolysates have potential in the fortification of acidic beverages, 
including soft drinks. Glutamine-rich hydrolysates are suggested as an optimal glutamine 
source for administration during periods of stress, such as recovery from strenuous exercise, 
or from surgery. Casein was selected as the protein for development of acid-soluble product 
and cereal protein for the glutamine-rich product. 
The main conclusions were as follows: 
 A number of protein hydrolysate products with value added properties and the 
processes required for their manufacture have been developed and are available for 
uptake by the food industry.  
 Laboratory investigations identified conditions for the generation of two casein 
hydrolysates with desirable functional properties.  
 Scale-up conditions for the manufacture of these hydrolysates in the pilot plant were 
successfully developed.  
 Both hydrolystates were 100% soluble at pH 4.6, exhibited clarity in solution at low 
pH in clear soft drinks and in caramelised beverages and were stable in solution over 
a wide temperature range (from 4 to 30ºC) for extended periods.  
 Solutions containing these hydrolysates exhibited no foaming properties and had 
acceptable sensory properties, being considered as weakly bitter compared to 
unsupplemented solutions. These performance characteristics make the acid-soluble 
hydrolysates useful supplements for caramelised beverages, such as colas, and 
clear soft drinks.  
 Six glutamine-enriched peptide products were produced at laboratory scale using two 
commercially available enzyme preparations. These products had desirable 
characteristics such as increased levels of peptide bound glutamine, low free amino 
acid and free pyroglutamate levels.  
 Pilot plant processes were developed for manufacture of the two glutamine-rich 
hydrolysates with most suitable compositional properties and these were fully 
characterised chemically. The manufacturing process was modified to enable 
industrial scale batches (5,000 litres) to be produced.  
Commercial Impacts 
 A patent application entitled "Glutamine-enriched peptide products" was filed in July 
1997.  
 A Food Ingredients company is currently assessing one of these glutamine peptide 
products for suitability for incorporation into health food drinks and supplements 
aimed at the American market.  
Research and Results 
a) Acid-Soluble Milk Protein Hydrolysate 
Hydrolysis of proteins is undertaken for a variety of reasons, including to improve the 
nutritional characteristics, retard deterioration, impart texture, increase or decrease solubility, 
add foaming or coagulation properties, add emulsifying capacity, prevent undesired 
interactions, remove off-flavours or odours, and/or to remove toxic or inhibitory ingredients. 
Hydrolysis can be accomplished by enzymes, acids or alkali, but protein hydrolysates 
resulting from enzymatic hydrolysis are far more desirable for nutritional purposes than those 
resulting from strictly chemical methods. 
Initially, a variety of whey protein hydrolysates were produced from whey protein concentrate 
(WPC) for protein enrichment of soft drinks. A range of hydrolysates were produced from 
undenatured and heat-denatured WPC by food-grade protease enzymes which exhibited 
optimal activity at acid pH. The hydrolysates were most soluble at the extremes of the pH 
curve, i.e. pH 3 and 7 (Fig. 1). Hydrolysates produced by the acid proteases Chymax and 
rennet from undenatured WPC exhibited greater solubility than the heat-denatured 
counterparts. At pH 3, both whey protein hydrolysates derived from undenatured WPC 
exhibited 100% solubility, while those derived from hydrolysis of heat-denatured WPC 
exhibited only 27-33% solubility. However, the clarity of all whey protein hydrolysates in 
acidic solutions was poor, and they all exhibited cloudiness. The cloudiness was not due to 
the fat content of WPC, because when a clarified defatted WPC (Provon, Avonmore) was 
used as the substrate for hydrolysis, the cloudiness remained when the resultant 
hydrolysates were incorporated into clear soft drinks. 
 Sensory analyses of clear soft drinks supplemented with the whey protein hydrolysates 
revealed that they could be detected and had an 'acidic' aftertaste. Addition of the whey 
protein hydrolysate (produced from undenatured WPC using the enzyme Chymax) to colas, 
which are acidic caramelised beverages, caused a colour change from the characteristic 
colour to a 'murky' brown, which could not be removed by filtration and which remained 
unchanged after several days at room temperature. When the pH of the colas was first 
neutralised, then supplementation with the whey protein hydrolysate caused no change in 
appearance of the solution. Therefore, the whey protein hydrolysates produced may be 
useful supplements for neutral, but not acidic beverages. 
As an alternative to WPC for the production of acid-soluble hydrolysate, acid casein was 
subsequently used as the substrate for enzymes with pH optima in the range 7 to 8. Enzyme 
combinations used in these experiments included Alcalase, mainly composed of 
endoprotease activity (Subtilisin Carlsberg) from Bacilluslicheniformis, Flavourzyme, which is 
a fungal protease/peptidase complex produced from Aspergillusoryzae, containing both 
endo and exopeptidase activities, DBP50 which is an exopeptidase preparation, specifically 
designed to reduce bitterness in hydrolysates and has pH optimum of 7.0 and temperature 
optimum of 50ºC and Corolase PP, which is a proteinase preparation from pig glands rich in 
trypsin and chymotrypsin activities. 
Two acid-soluble casein hydrolysates were manufactured successfully at lab-scale and pilot-
scale, using two different sets of enzymes. During the course of this project, however, the 
enzyme Corolase PP, which was used in the production of one of the casein hydrolysates 
was withdrawn from the market, so the information below pertains to that casein hydrolysate 
which was manufactured using the second enzyme combination. The hydrolysates were 
characterised chemically and functionally. All peptides were less than 1500 D (Fig. 2) 
indicating that the hydrolysate was extensively hydrolysed and contained peptides no longer 
than 11 residues (based on average Mw/residue of 125 D). The protein content of the spray-
dried product was 78-80%, lactose was <0.2%, fat was <1%, moisture was 6%, ash was 
16% and pH was 4.6. The hydrolysate was easily dispersible, exhibiting clarity, solubility and 
stability in solution at low pH, being 100% soluble at pH 4.6 with no quantifiable foaming 
properties and the hydrolysate formed low viscosity solutions at high protein concentrations. 
When compared to an existing commercially available acid-soluble casein hydrolysate 
(Peptigen 901), the performance of the pilot-scale hydrolysate was superior. In this regard, 
the pilot-scale hydrolysate was a useful supplement for caramelised beverages, such as 
colas, in addition to clear soft drinks, while the commercial hydrolysate was only useful in 
clear soft drinks. Upon addition of the commercial casein hydrolysate to a cola-type drink, a 
colour change similar to that observed upon addition of the whey protein hydrolysate was 
obtained. In addition, the pilot-scale hydrolysate was considered only weakly bitter by a 
trained sensory panel and compared favourably with the commercial hydrolysate in terms of 
sensory criteria. 
 
Fig. 2. Peptide Size Distribution in the Acid-Soluble Casein Hydro-lysate 
This extensively hydrolysed protein product possessed the desired functional and 
physicochemical properties for fortification of such products as acidic beverages, both clear 
and caramelised, in addition to health, energy and sports drinks. The nutritional benefits and 
amino acid profile of the protein in the casein hydrolysate was similar to casein from which it 
was derived. Therefore, because of the high biological value of the protein in the 
hydrolysate, it may be used as the sole protein source, or in combination with other proteins, 
depending on the application. Furthermore, the hydrolysate in solution showed stability upon 
heat treatment, thereby allowing formulations based on the product to be autoclaved. 
b) Glutamine-enriched peptide hydrolysates 
Glutamine has a range of physiological effects. For example, glutamine is involved in the 
rapid restoration of muscle glycogen levels following periods of vigorous exercise and is 
therefore required in the rapid recovery from exercise. It stimulates the immune system and 
is therefore required for rapid recovery from infections or sepsis and in wound repair as 
pertains in the situation of post operative patients. There is a considerable body of evidence 
to show that glutamine plays a role in the maintenance/restoration of nitrogen balance. 
Glutamine is also important in oral rehydration and has a role in preservation of mucosal 
structure following periods of parenteral nutrition. Glutamine is considered a non essential 
amino acid as it can be synthesised in the body. However, during periods of metabolic 
stress, glutamine cannot be synthesised as quickly as it is required and as a consequence 
plasma glutamine levels are severely depleted. Glutamine is therefore considered as a 
conditionally essential amino acid. 
It is evident from the above that glutamine can be considered as an ingredient in the 
formulation of "physiologically functional foods". In the free form, glutamine is insoluble in 
solution, and is unstable at high temperatures, as it cyclises to form pyroglutamate which is 
toxic. In contrast, glutamine in peptide bound form has improved solubility, is absorbed faster 
into the bloodstream and is more stable at high temperatures, thus markedly improving its 
suitability for food supplementation. Glutamine peptide enriched hydrolysate products should 
ideally have a number of characteristics. These include, high peptide bound glutamine 
contents (i.e. > 25% peptide bound glutamine), low levels of free amino acids and low free 
glutamine levels in order to minimise pyroglutamate formation. Furthermore, in order to 
facilitate efficient absorption, glutamine peptide enriched products should have low levels of 
high molecular mass material and high levels of low molecular mass material. The objective 
of this section of the project was therefore to develop glutamine peptide enriched products 
having all or most of the above characteristics. 
Table 1: Comparative characteristics of large scale glutamine-enriched hydrolysate products 
  DPCGP6001 DPCGP6002 Commercial 
product 1 
Commercial 
product 2 
Protein % (w/w) 74.44 77.78 73.61 82.31 
%Free amino acids 3.21 3.05 3.92 0.39 
%Free glutamine 0.035 0.015 0.020 0.008 
%Peptide bound 
glutamine 
28.60 29.07 19.70 32.39 
%Pyroglutamate 0.42 1.23 2.21 0.01 
          
Molecular mass 
distribution profiles 
(%)* 
        
>10kDa 1.21 1.04 0.07 26.67 
<3 kDa 94.44 97.12 98.1 43.65 
<1 kDa 77.87 84.70 86.39 23.85 
          
Solubility >99% pH 2-
8 
> 98% pH 2-
8 
>98% ph2-3, 
5-7 94% 
pH4 
>97.5% pH 2-
8 
Clarity >99% pH 2-
8 
>98% pH 2-
8 
> 98% pH 2-
8 
>98% pH 2-3 
< 98% pH 4-8 
Acid stability No turbidity No turbidity No turbidity ND 
Heat stability 
(80ºCx10mins) 
No reduction 
of glutamine 
No reduction 
of glutamine 
No reduction 
of 
glutamine 
1.51g/100g 
reduction of 
glutamine 
Osmolality (mOsm/kg) 20.00 18.00 34.00 28.00 
*Values expressed as % total area for a gel permeation profile obtained at 214 nm 
ND = Not determined 
Initially, analytical methods were developed to assay hydrolysates for peptide bound 
glutamine, free glutamine and free pyroglutamate contents. Milk and cereal proteins were 
then investigated as potential sources of glutamine-enriched peptides. Cereal proteins are 
naturally rich in glutamic acid and as such were selected as good substrates for the 
preparation of glutamine-enriched peptide hydrolysates. An extensive screening programme 
was carried out and two commercial enzyme preparations were identified at laboratory-scale 
which generated glutamine-enriched peptide preparations having high levels of peptide 
bound glutamine. Using the selected enzyme preparations, pilot-scale trials (200 1) were 
carried out which yielded kilogram quantities of glutamine-enriched prototype products. 
These prototype products (DPCGP6001 and DPCGP6002) were extensively characterised 
and were shown to have characteristics superior to some commercially available products 
(Table 1). When compared to commercially available product, the DPC products were shown 
to have increased levels of peptide-bound glutamine while retaining other desirable 
characteristics such as low free amino acid, low free glutamine and low free pyroglutamate 
levels. Table 1 shows that commercially available product 2 has a high peptide bound 
glutamine content (> 30%), and low free amino acid, free glutamine and free pyroglutamate 
levels. However, the molecular mass distribution profile for this product shows a high 
percentage of material greater than 10 kDa. Commercially available product 2 does not 
display the same clarity in solution as DPC 1 and 2. DPCGP6001 and DPCGP6002 have 
lower osmolarity values than both commercially available products, this is favourable in 
terms of rapid absorption. 
  
Table 2: Characteristics of glutamine-enriched hydrolysate produced at industrial scale 
  DPCGP6001 
Protein (g/100g powder) 83.14 
Moisture (g/100g powder) 3.09 
Ash (g/100g powder) 8.6 
Fat (g/100g powder) 0.22 
Free Amino Acids (g/100g powder)   
2.18   
Free Glutamine (g/100g powder) 0.031 
Peptide Bound Glutamine (g/100g 
powder) 
29.06 
Pyroglutamate (g/100g powder) 0.33 
    
Molecular Mass Distribution Profile *   
> 10kDa   
0.29   
< 3 kDa 96.44 
< 1 kDa 79.12 
    
Clarity >98% pH 2-3, >94% pH 4-6, 92% pH 
7.8 
Appearance White free flowing powder 
Total Bacterial Count (per g of sample) 5900 
Coliforms (per g of sample) <10 
pH of Reconstituted Sample 6.4 
* values expressed as % total area for a gel permeation profile obtained at 214 nm 
Industrial scale trials (5000 1) were performed following commercial interest in the products. 
As can be seen from Table 2, the glutamine-enriched product developed at industrial scale 
retained the favourable physicochemical characteristics of the hydrolysates produced at pilot 
scale. The industrial scale process also included a process modification which leads to an 
improved production process. Supplementation of orange juice and clear soft drinks with the 
glutamine-enriched peptide products yielded very acceptable drinks. An Irish food 
ingredients company is currently evaluating the American and European markets for the 
glutamine peptide products. A patent application was filed to protect each of the enriched 
glutamine peptide products prepared during the course of the project. 
Pilot scale production of protein hydrolysis. 
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